(1)
EVALUATION OF EFFICACY OF PROPHYLACTICALLY USED PREMEDICATION FOR THE MANAGEMENT OF NAUSEA, VOMITING AND HYPERSENSITIVITY REACTIONS TO CISPLATIN, TAXANES AND FAC (5-FLUOROURACIL, ADRIAMYCIN (DOXORUBICIN) AND CYCLOPHOSPHAMIDE) BASED CHEMOTHERAPY:. J Popl Ther Clin Pharmacol 2024, 31 (9), 769-776. https://doi.org/10.53555/y6s67361.